#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal squamous cell carcinoma stage III Malignant melanoma Pulmonary alveolar haemorrhage Hyperoxaluria B-cell lymphoma refractory Skin cancer Myotonia Cutaneous T-cell lymphoma refractory Vernal keratoconjunctivitis Fallopian tube cancer Lymphangioma Small for dates baby Dilated cardiomyopathy SAPHO syndrome Nodal marginal zone B-cell lymphoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Trials in Disease Mast cell activation syndrome – Trials in Disease Lymphangioma – Trials in Disease Advanced systemic mastocytosis – Life with Disease Atypical teratoid/rhabdoid tumour of CNS Mucopolysaccharidosis – Diagnostics Ewing’s sarcoma metastatic Medulloblastoma – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Chondrosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clebopride Hydrogen Maleate Methylphenidate Hydrochloride Blomia Tropicalis Dordaviprone ABBV-8736 Dexchlorpheniramine SGN-ALPV Ecoo25B USNOFLAST Dorzolamide Melphalan Hydrochloride Nemtabrutinib Tepotinib Canis Familiaris (553) Cefalexin Tretinoin IMELASOMERAN Leflunomide Bomedemstat Exemestane More therapies…

    Learn about Your Condition

    Vulvovaginal candidiasis Erythema multiforme Aplasia pure red cell Post cardiac arrest syndrome Extra-osseous Ewing's sarcoma Large cell lung cancer stage 0 Portal hypertension Heart disease congenital Hypoxia Genital herpes simplex Choreoathetosis Transient ischaemic attack Liver transplant Encephalopathy neonatal Peripheral spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Clofazimine and Drug Combination for Treating Mycobacterium abscessus Lung Disease in Adult Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mycobacterium abscessus infection
    Investigated Drugs:
    • Amikacin
    • Azithromycin
    • Bedaquiline
    Denmark

  • Study on Mifepristone and Letrozole for Treating Ectopic Pregnancy in Comparison to Methotrexate

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mifepristone
    • Methotrexate
    • Letrozole
    Denmark Finland Latvia Sweden

  • Study on Treating Adynamic Bone Disorder with Teriparatide in Patients with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Teriparatide
    Denmark

  • Study on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab
    • Inavolisib
    Belgium Germany Italy Poland Romania Slovakia +1

  • Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Lapatinib
    • Nintedanib
    • Goserelin Acetate
    Spain

  • Study on Early Diffuse Cutaneous Systemic Sclerosis: Comparing Stem Cell Transplantation with Cyclophosphamide, Filgrastim, and Mycophenolate Mofetil

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Filgrastim
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Italy The Netherlands Sweden
Previous Page
1 … 596 597 598 599 600 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!